Induction of ovulation with phenobarbital in anovulatory states: a preliminary report.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy; D001706:Biopsy; D001831:Body Temperature; D002784:Cholesterol / Q000097:blood; D003345:Corticosterone / Q000652:urine; D004717:Endometrium / Q000473:pathology; D004967:Estrogens / Q000652:urine; D005260:Female; D006628:Hirsutism; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008598:Menstruation; D008599:Menstruation Disturbances / Q000188:drug therapy; D010048:Ovarian Cysts / Q000139:chemically induced; D010060:Ovulation / Q000187:drug effects*; D010634:Phenobarbital / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D011085:Polycystic Ovary Syndrome; D011247:Pregnancy; D011276:Pregnanediol / Q000652:urine; D013268:Stimulation, Chemical; D014626:Vaginal Smears
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D004967:Estrogens; D002784:Cholesterol; D011276:Pregnanediol; D003345:Corticosterone; D006854:Hydrocortisone; D010634:Phenobarbital